Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Impact of European vaccination policies on seasonal influenza vaccination coverage rates: An update seven years later

PR. Blank, GA. van Essen, R. Ortiz de Lejarazu, J. Kyncl, A. Nitsch-Osuch, EP. Kuchar, O. Falup-Pecurariu, HC. Maltezou, D. Zavadska, Z. Kristufkova, G. Kassianos,

. 2018 ; 14 (11) : 2706-2714. [pub] 20180827

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19028367
E-zdroje Online Plný text

NLK Free Medical Journals od 2012 do Před 1 rokem
PubMed Central od 2012 do Před 1 rokem
Europe PubMed Central od 2012 do Před 1 rokem

Odkazy

PubMed 29923782
DOI 10.1080/21645515.2018.1489948
Knihovny.cz E-zdroje

Seasonal influenza can have serious morbid consequences and can even result in death, particularly in at-risk populations, including healthcare professionals (HCPs), elderly and those living with a medical risk condition. Although in Europe recommendations exist for annual influenza vaccination in these populations in most countries, the vaccination coverage rate (VCR) is often well below the World Health Organization target of 75% coverage. In our previous survey in 2009 we showed that some elements of national vaccination policies, e.g. reminder systems, strong official recommendation, and easy access, seemed to contribute to achieving higher influenza VCRs among elderly. We repeated the survey in 2016, using the same methodology to assess changes in influenza VCRs among the elderly and in the impact of policy elements on these VCRs. In addition, we collected information about VCRs among HCPs, and those living with a medical risk condition. The median VCR in the 21 countries that had recommendations for influenza vaccination in the elderly was 35.3%, ranging from 1.1% in Estonia to 74.5% in Scotland. The average VCRs for HCPs and those living with medical risk conditions, available in 17 and 10 countries, respectively, were 28.3% (range 7% in Czech Republic to 59.1% in Portugal) and 32.2% (range from 20.0% in the Czech Republic and Hungary to 59.6% in Portugal), respectively. Fewer countries were able to provide data from HCP and those living with medical risk conditions. Since the initial survey during the 2007-2008 influenza season, VCRs have decreased in the elderly in the majority of countries, thus, achieving high VCRs in the elderly and the other target groups is still a major public health challenge in Europe. This could be addressed by the identification, assessment and sharing of best practice for influenza vaccination policies.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19028367
003      
CZ-PrNML
005      
20190822124520.0
007      
ta
008      
190813s2018 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1080/21645515.2018.1489948 $2 doi
035    __
$a (PubMed)29923782
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Blank, Patricia R $u a University of Zurich, Epidemiology, Biostatistics and Prevention Institute (EBPI) , Zürich , Switzerland.
245    10
$a Impact of European vaccination policies on seasonal influenza vaccination coverage rates: An update seven years later / $c PR. Blank, GA. van Essen, R. Ortiz de Lejarazu, J. Kyncl, A. Nitsch-Osuch, EP. Kuchar, O. Falup-Pecurariu, HC. Maltezou, D. Zavadska, Z. Kristufkova, G. Kassianos,
520    9_
$a Seasonal influenza can have serious morbid consequences and can even result in death, particularly in at-risk populations, including healthcare professionals (HCPs), elderly and those living with a medical risk condition. Although in Europe recommendations exist for annual influenza vaccination in these populations in most countries, the vaccination coverage rate (VCR) is often well below the World Health Organization target of 75% coverage. In our previous survey in 2009 we showed that some elements of national vaccination policies, e.g. reminder systems, strong official recommendation, and easy access, seemed to contribute to achieving higher influenza VCRs among elderly. We repeated the survey in 2016, using the same methodology to assess changes in influenza VCRs among the elderly and in the impact of policy elements on these VCRs. In addition, we collected information about VCRs among HCPs, and those living with a medical risk condition. The median VCR in the 21 countries that had recommendations for influenza vaccination in the elderly was 35.3%, ranging from 1.1% in Estonia to 74.5% in Scotland. The average VCRs for HCPs and those living with medical risk conditions, available in 17 and 10 countries, respectively, were 28.3% (range 7% in Czech Republic to 59.1% in Portugal) and 32.2% (range from 20.0% in the Czech Republic and Hungary to 59.6% in Portugal), respectively. Fewer countries were able to provide data from HCP and those living with medical risk conditions. Since the initial survey during the 2007-2008 influenza season, VCRs have decreased in the elderly in the majority of countries, thus, achieving high VCRs in the elderly and the other target groups is still a major public health challenge in Europe. This could be addressed by the identification, assessment and sharing of best practice for influenza vaccination policies.
650    _2
$a senioři $7 D000368
650    _2
$a předškolní dítě $7 D002675
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a zdravotnické plány - realizace $x organizace a řízení $x statistika a číselné údaje $7 D006284
650    12
$a zdravotní politika $7 D006291
650    _2
$a lidé $7 D006801
650    _2
$a očkovací programy $x organizace a řízení $x statistika a číselné údaje $7 D017589
650    _2
$a kojenec $7 D007223
650    _2
$a chřipka lidská $x prevence a kontrola $7 D007251
650    _2
$a lidé středního věku $7 D008875
650    _2
$a těhotenství $7 D011247
650    _2
$a roční období $7 D012621
650    _2
$a pokrytí očkováním $x statistika a číselné údaje $7 D000073887
651    _2
$a Evropa $7 D005060
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a van Essen, Gerrit Adrianus $u b General Practitioner , Amersfoort , The Netherlands.
700    1_
$a Ortiz de Lejarazu, Raúl $u c Valladolid National Influenza Center, Microbiology and Immunology Department, Hospital Clinicon , Valladolid , Spain.
700    1_
$a Kyncl, Jan $u d Department of Infectious Diseases Epidemiology , National Institute of Public Health , Prague , Czech Republic. e Department of Epidemiology and Biostatistics, Third Faculty of Medicine , Charles University , Prague , Czech Republic.
700    1_
$a Nitsch-Osuch, Aneta $u f Department of Social Medicine and Public Health , Medical University of Warsaw , Warsaw , Poland.
700    1_
$a Kuchar, Ernest Piotr $u g Department of Paediatrics with Clinical Assessment Unit , Medical University of Warsaw , Warsaw , Poland.
700    1_
$a Falup-Pecurariu, Oana $u h Department of Pediatrics, Children's Clinic Hospital, Faculty of Medicine , Transilvania University Brasov , Brasov , Romania.
700    1_
$a Maltezou, Helena C $u i Hellenic Center for Disease Control and Prevention , Athens , Greece.
700    1_
$a Zavadska, Dace $u j Department of Pediatrics , Riga Stradins University , Riga , Latvia.
700    1_
$a Kristufkova, Zuzana $u k Faculty of Public Health , Slovak Medical University , Bratislava , Slovak Republic.
700    1_
$a Kassianos, George $u l Royal College of General Practitioners , Wokingham , Berkshire , UK.
773    0_
$w MED00181409 $t Human vaccines & immunotherapeutics $x 2164-554X $g Roč. 14, č. 11 (2018), s. 2706-2714
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29923782 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20190822124759 $b ABA008
999    __
$a ok $b bmc $g 1433516 $s 1066827
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 14 $c 11 $d 2706-2714 $e 20180827 $i 2164-554X $m Human vaccines & immunotherapeutics $n Hum Vaccin Immunother $x MED00181409
LZP    __
$a Pubmed-20190813

Najít záznam

Citační ukazatele

Možnosti archivace